| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 May 2025 | 19 May 2025 |
| Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve 1. To consider and approve the Audited Financial Results of the Company for the quarter and Financial Year ended 31st March 2025. 2. To consider the appointment of M/s Sanghi & Co. Chartered Accountants as the Internal Auditor of the Company for the F.Y. 2025-26. 3. To carry on any other business with the permission of the Board. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Wednesday, 28th May, 2025 at 04:30 P.M at the corporate office of the company at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded at 6 : 10 P.M has considered and approved the Standalone Audited Financial Results of the Company alongwith Auditors Report for the Standalone Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2025. (As Per BSE Announcement Dated on :28.05.2025) | ||
| Board Meeting | 13 Mar 2025 | 13 Mar 2025 |
| Outcome of independent Directors meeting held today i.e 13.03.2025 at 3:00 P.M and concluded at 3:55 P.M | ||
| Board Meeting | 12 Feb 2025 | 25 Jan 2025 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the Un-audited Financial Results along with limited review report of the company for the quarter and nine months ended 31st December 2024. Outcome of the Board Meeting and Submission of Un-audited Financial Results for the quarter ended 31st December, 2024 as required u/r 33 of the SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on: 12/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 30 Oct 2024 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations 2015 notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations 2015 a meeting of the Board of Directors of the company is scheduled to be held on Thursday 14 th November2024 at 12:00 P.M. at the corporate office of the company at 703 Arunachal Building 19 Barakhambha Road Connaught Place New Delhi-110001 to inter-alia consider and approve the Unaudited Financial Results of the Company & Limited Review Report thereon for the quarter and half year ended 30 th September 2024 and to carry on any other business with the permission of the Board. Outcome of the Board Meeting held today i.e 14.11.2024 at 12 : 00 P.M and concluded at 1:55 P.M has already duly been uploaded withing the stipulated time period under Reg 33 of SEBI (LODR ) Regulations, 2015 (As Per BSE Announcement Dated on: 14/11/2024) | ||
| Board Meeting | 2 Sep 2024 | 28 Aug 2024 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2024 inter alia to consider and approve the agendas enclosed herewith . Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we wish to inform you that Board of Directors in its meeting held today i.e. on Monday, 2nd September, 2024 at 04:00 P.M. at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001, and concluded at 04:47 P.M. has inter-alia to transact the enclosed businesses. (As per BSE Announcement Dated on 02/09/2024) | ||
| Board Meeting | 13 Aug 2024 | 30 Jul 2024 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the Un-audited Financial Results of the company for the quarter ended 30th June 2024 submission of un-audited financial results for the quarter ended 30.06.2024 Board Meeting to consider and approve the Standalone Un-audited Financial Results of the Company for the quarter ended 30th June, 2024. (As Per BSE Announcement Dated on 13.08.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.